logo-loader

Grey Matters Health achieves medicare and medicaid enrollment for Florida NovaScan Clinic

Published: 04:55 18 Nov 2026 AEDT

Grey Matters Health CEO Christopher Moreau joined Steve Darling from Proactive to announce a major commercial milestone for the company's flagship NovaScan Neuroimaging Clinics™ location in Davie, Florida, which has received accreditation and completed its full enrollment in both US Medicare and Medicaid programs.

The accreditation and enrolment allow the clinic to provide covered diagnostic imaging services to eligible Medicare and Medicaid patients, while also positioning it to pursue in-network agreements with private insurers.

Moreau told Proactive that accreditation is an important step for the company's commercial rollout because US diagnostic imaging centres must meet accreditation requirements to complete Medicare enrolment and receive reimbursement for eligible services.

With the Davie clinic now fully enrolled, patients can access covered brain PET scans through established billing codes for the imaging procedures and the associated radioactive isotopes used in the diagnostic process.

The inaugural NovaScan Neuroimaging Clinics location is situated in the HCA Florida University Medical Office Building on the campus of HCA Florida University Hospital in Davie.

The facility is described by the company as the first of its kind in the United States to offer dedicated brain PET scanning services designed to assist in detecting Alzheimer's disease and other neurodegenerative conditions.

The accreditation also provides referring physicians with independent validation that the imaging centre meets recognized standards for image quality, reliable scan reporting, qualified personnel and patient safety protocols.

NovaScan clinics will feature the US FDA-cleared CareMiBrain™ system, a dedicated brain PET scanner designed with a comfortable, chair-style configuration.

Grey Matters noted that brain PET scans for beta-amyloid plaque detection are covered by Medicare, Medicaid and most private insurers for eligible patients aged 65 and older.

The company views the Davie clinic's accreditation and completed government-program enrolment as an important step in establishing its business model and expanding access to specialized brain imaging services across the United States.

#proactiveinvestors #greymettershealth #cse #grey #AlzheimersDisease #Neuroimaging #PETScan #HealthcareInnovation #BrainHealth #DementiaResearch #MedicalTechnology #NovaScan #HealthcareServices #MedicalTechnology #Parkinsons #HealthTech #DiagnosticImaging #HCAFloridaUniversityMedicalOfficeBuilding

XanaMIA results: What's next for Actinogen Medical?

Actinogen Medical Ltd CEO Dr Steven Gourlay talked with Proactive about the topline results from the company's XanaMIA clinical trial, which evaluated its investigational Alzheimer's disease treatment Xanamem. The study revealed encouraging signs of disease slowing in patients aged...

9 hours, 44 minutes ago